Trial intelligence / Profile preview

5% nicotinamide cream for actinic keratosis of the forearms

RBR-6m7tyhfRecruiting

Sponsor
UNESP Botucatu Medical School
Start
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of nicotinamide in actinic keratosis (AK) (2 arms), sponsored by UNESP Botucatu Medical School. Started Mar 2021; status: recruiting.

02

Drugs

nicotinamide
03

Conditions

actinic keratosis (AK)

Beyond the preview

Go deeper on RBR-6m7tyhf.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-6m7tyhf.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call